Dr. Jim Collins Receives Intramural NIH Award To Increase CMD Biomarker Discovery

Congratulations to Dr. Jim Collins, MD, PhD at Cincinnati Children’s Hospital Medical Center.  Dr. Collins has received an intramural NIH CCTST translational KL2 award. This award will allow him to enroll additional children with Merosin Deficient CMD and Collagen VI CMD.  Dr. Collins was initially funded by a Cure CMD/SAM Research Grant for a pilot biomarker study.  Investing in promising research helps drive additional funding support.   Dr. Collins is targeting enrolling at least 40 children with both subtypes.   Travel support available.
For more information:
Contact: Shengyong Hu (Division of Neurology, Cincinnati Children’s Hospital Medical Center)
Phone: 513-636-3202 or 513-636-7451
Email: shengyong.hu@cchmc.org


This entry was posted in Research News. Bookmark the permalink. Both comments and trackbacks are currently closed.
  • Congenital Muscular Dystrophy

    A group of diseases causing muscle weakness at birth. Several defined genetic mutations cause muscles to break down faster than they can repair or grow. A child with CMD may have various neurological or physical impairments. Some children never gain the ability to walk, while others lose the ability as they grow older. Learn more...

  • Register Now!